Deliberate Dysentery
Codon
JANUARY 21, 2024
The European Medicines Agency (EMA) is similar in this regard, although interestingly, that’s not the case in the United Kingdom, where regulators are not so directly involved in assessing a challenge study beforehand. The challenge agent also has to be produced under very stringent protocols. So that's a drawback.
111 
Let's personalize your content